StockMirror — Stock Screener

EPIGRAL Q2 FY27 Results & Earnings Analysis

Sentiment: Neutral (Confidence: medium)

Earnings Summary

Epigral reported Q2 FY27 revenue growth of 28% YoY to INR752 crores, driven by volume growth and improved realizations, with PAT growing 26% to INR64 crores. However, EBITDA margins remained under pressure at 18% due to high raw material and energy costs from West Asia volatility and increased coal prices. The derivatives and specialty business contributed 57% of revenue. Management highlighted ongoing capex for CPVC and ECH expansions, progress on epoxy resin and MPP projects, and initiatives to reduce energy costs through renewables. The outlook for H2 FY27 is positive, with expectations of higher caustic soda prices and continued volume growth.

Management Tone

Revenue Growth Drivers

Growth vs Margin Focus

Management emphasized revenue growth of 28% YoY while acknowledging margin pressure and taking steps to mitigate costs through renewable energy and value-added products. Long-term target of INR5,000 crores revenue by FY31 with EBITDA margin in the range of 22-23%.

About Epigral Limited

Epigral Limited (EPIGRAL) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.

Explore More